Literature DB >> 22130542

A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection.

Wei Xin Khong1, Benedict Yan, Huimin Yeo, Eng Lee Tan, Jia Jun Lee, Jowin K W Ng, Vincent T Chow, Sylvie Alonso.   

Abstract

Enterovirus 71 (EV71) is a neurotropic pathogen that has been consistently associated with the severe neurological forms of hand, foot, and mouth disease. The lack of a relevant animal model has hampered our understanding of EV71 pathogenesis, in particular the route and mode of viral dissemination. It has also hindered the development of effective prophylactic and therapeutic approaches, making EV71 one of the most pressing public health concerns in Southeast Asia. Here we report a novel mouse model of EV71 infection. We demonstrate that 2-week-old and younger immunodeficient AG129 mice, which lack type I and II interferon receptors, are susceptible to infection with a non-mouse-adapted EV71 strain via both the intraperitoneal (i.p.) and oral routes of inoculation. The infected mice displayed progressive limb paralysis prior to death. The dissemination of the virus was dependent on the route of inoculation but eventually resulted in virus accumulation in the central nervous systems of both animal groups, indicating a clear neurotropism of the virus. Histopathological examination revealed massive damage in the limb muscles, brainstem, and anterior horn areas. However, the minute amount of infectious viral particles in the limbs from orally infected animals argues against a direct viral cytopathic effect in this tissue and suggests that limb paralysis is a consequence of EV71 neuroinvasion. Together, our observations support that young AG129 mice display polio-like neuropathogenesis upon infection with a non-mouse-adapted EV71 strain, making this mouse model relevant for EV71 pathogenesis studies and an attractive platform for EV71 vaccine and drug testing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130542      PMCID: PMC3302383          DOI: 10.1128/JVI.06103-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Retrograde axonal transport: a major transmission route of enterovirus 71 in mice.

Authors:  Che-Szu Chen; Yi-Chuan Yao; Shin-Chao Lin; Yi-Ping Lee; Ya-Fang Wang; Jen-Ren Wang; Ching-Chuan Liu; Huan-Yao Lei; Chun-Keung Yu
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

2.  White matter damage in neonatal enterovirus meningoencephalitis.

Authors:  M A Verboon-Maciolek; F Groenendaal Utrecht; F Cowan; P Govaert; A M van Loon; L S de Vries
Journal:  Neurology       Date:  2008-08-12       Impact factor: 9.910

3.  Type-I but not type-II interferon receptor knockout mice are susceptible to biliary atresia.

Authors:  Joachim F Kuebler; Gerard Czech-Schmidt; Johannes Leonhardt; Benno M Ure; Claus Petersen
Journal:  Pediatr Res       Date:  2006-04-26       Impact factor: 3.756

Review 4.  The pathogenesis of poliomyelitis: what we don't know.

Authors:  Neal Nathanson
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

5.  The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways.

Authors:  Kum Thong Wong; Badmanathan Munisamy; Kien Chai Ong; Hideaki Kojima; Nagata Noriyo; Kaw Bing Chua; Beng Beng Ong; Kazuo Nagashima
Journal:  J Neuropathol Exp Neurol       Date:  2008-02       Impact factor: 3.685

6.  Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis.

Authors:  Kien Chai Ong; Munisamy Badmanathan; Shamala Devi; Kum Loong Leong; Mary Jane Cardosa; Kum Thong Wong
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

7.  Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons.

Authors:  Kate D Ryman; Kathryn C Meier; Christina L Gardner; Patrick A Adegboyega; William B Klimstra
Journal:  Virology       Date:  2007-08-02       Impact factor: 3.616

8.  Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study.

Authors:  Mong How Ooi; See Chang Wong; Yuwana Podin; Winnie Akin; Syvia del Sel; Anand Mohan; Chae Hee Chieng; David Perera; Daniela Clear; Darin Wong; Emma Blake; Jane Cardosa; Tom Solomon
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

9.  Multiple host barriers restrict poliovirus trafficking in mice.

Authors:  Sharon K Kuss; Chris A Etheredge; Julie K Pfeiffer
Journal:  PLoS Pathog       Date:  2008-06-06       Impact factor: 6.823

10.  Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication.

Authors:  Zhao-Hong Li; Chien-Ming Li; Pin Ling; Fang-Hsiu Shen; Shih-Heng Chen; Ching-Chuan Liu; Chun-Keung Yu; Shun-Hua Chen
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

View more
  84 in total

1.  Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.

Authors:  Zhenjie Zhang; Zhaopeng Dong; Juan Li; Michael J Carr; Dongming Zhuang; Jianxing Wang; Yawei Zhang; Shujun Ding; Yigang Tong; Dong Li; Weifeng Shi
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  A Novel Murine Model Expressing a Chimeric mSCARB2/hSCARB2 Receptor Is Highly Susceptible to Oral Infection with Clinical Isolates of Enterovirus 71.

Authors:  Cheng-Hung Yang; Chung-Tiang Liang; Si-Tse Jiang; Kuan-Hsing Chen; Chun-Chiao Yang; Mei-Ling Cheng; Hung-Yao Ho
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

3.  Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice.

Authors:  Juhao Yang; Chunfu Yang; Nining Guo; Kai Zhu; Kaiming Luo; Na Zhang; Hui Zhao; Ying Cui; Lei Chen; Hongyang Wang; Jun Gu; Baoxue Ge; Cheng-Feng Qin; Qibin Leng
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

4.  Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.

Authors:  Chun-Che Liao; An-Ting Liou; Ya-Shu Chang; Szu-Yao Wu; Chih-Shin Chang; Chien-Kuo Lee; John T Kung; Pang-Hsien Tu; Ya-Yen Yu; Chi-Yung Lin; Jen-Shiou Lin; Chiaho Shih
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

5.  In Vivo Imaging with Bioluminescent Enterovirus 71 Allows for Real-Time Visualization of Tissue Tropism and Viral Spread.

Authors:  Elizabeth A Caine; Jorge E Osorio
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

Review 6.  Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality.

Authors:  Kevin Messacar; Edwin J Asturias; Alison M Hixon; Coretta Van Leer-Buter; Hubert G M Niesters; Kenneth L Tyler; Mark J Abzug; Samuel R Dominguez
Journal:  Lancet Infect Dis       Date:  2018-02-23       Impact factor: 25.071

7.  Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.

Authors:  Yanyan Ke; Wai Nam Liu; Zhisheng Her; Min Liu; Sue Yee Tan; Yong Wah Tan; Xue Ying Chan; Yong Fan; Edwin Kunxiang Huang; Huiyi Chen; Kenneth Tou En Chang; Jerry Kok Yen Chan; Justin Jang Hann Chu; Qingfeng Chen
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

Review 8.  Progress on the research and development of human enterovirus 71 (EV71) vaccines.

Authors:  Zhenglun Liang; Qunying Mao; Fan Gao; Junzhi Wang
Journal:  Front Med       Date:  2012-12-17       Impact factor: 4.592

9.  A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.

Authors:  Elizabeth A Caine; Louise H Moncla; Monica D Ronderos; Thomas C Friedrich; Jorge E Osorio
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.

Authors:  Donald F Smee; W Joseph Evans; K C Nicolaou; E Bart Tarbet; Craig W Day
Journal:  Antiviral Res       Date:  2016-04-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.